Drug Profile
Research programme: metabolic syndrome therapies - Indigene Pharmaceuticals
Alternative Names: IG-MD-014Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Indigene Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Metabolic syndrome
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Metabolic-syndrome in India
- 07 Oct 2009 Early research in Metabolic syndrome in India (unspecified route)